Overview
Dr. Shu-Ben Li is a Professor, Chief Physician, and PhD Supervisor. He serves as Administrative Deputy Director of the Thoracic Surgery Department and Head of the Trachea and Lung Surgery Subspecialty at the First Affiliated Hospital of Guangzhou Medical University (National Center for Respiratory Medicine). He is a Postdoctoral Fellow of Harvard Medical School and Research Fellow at Massachusetts General Hospital (MGH). Recognized as a Guangdong Outstanding Young Medical Talent and Guangzhou High-Level Talent Outstanding Expert.
Clinical focus & conditions
1. Advanced Airway & Tracheal Surgery
Tracheal Oncology: Surgical management of primary and secondary tracheal tumors.
Carinal Reconstruction: Expert resection and reconstruction of Carinal Tumors.
Airway Stenosis: Treatment for benign and malignant tracheobronchial narrowing.
Complex Airway Diseases: Specialized care for refractory respiratory tract disorders.
2. Thoracic Oncology
Lung Cancer: Full-spectrum management from Early-stage to Locally Advanced cases.
Pulmonary Nodules: Precision resection of small nodules and Ground-Glass Opacities (GGO/GGN).
Mediastinal & Thymic: Surgery for thymoma, germ cell tumors, and mediastinal masses.
3. Total Respiratory Tract Tumors
Integrated Care: Management of tumors spanning the larynx, trachea, and lungs.
MDT Approach: Comprehensive treatment for multi-site respiratory malignancies.
Education & training
MD,Ph.D. — Harvard Medical School
Training — Research Fellow at Massachusetts General Hospital
Hospital affiliations
The first affiliated hospital of Guangzhou medical university
Honors & Research
Honors:
Guangdong First Batch Outstanding Young Medical Talent, Guangzhou High-Level Talent Outstanding Expert; First Prize of Chinese Medical Science and Technology Award, First Prize of Huaxia Medical Award, etc.
Academic Positions:
Vice Chairman of Thoracic Surgery Committee, Rehabilitation Branch, China Anti-Cancer Association; Vice Chairman of Thoracic Surgery Committee, Guangdong Pharmaceutical Association; Editorial Board Member of Translational Lung Cancer Research (TLCR, IF=6.498), among others.
Research:
Led multiple national, provincial, and municipal key projects; published multiple SCI papers; holds national patents. Leading position in China/internationally in complex tracheal reconstruction, Tubeless minimally invasive surgery, robotic-assisted tracheal/carinal reconstruction, and autologous lung lobe transplantation after neoadjuvant therapy.
Is my case a fit for a second opinion?
A second opinion is often helpful if you have a new diagnosis multiple treatment options discordant pathology or imaging results progression/recurrence or you want confirmation before starting therapy.
•Good fit: complex decisions uncertainty multiple lines of therapy clinical trial questions.
•Not a fit: emergencies (e.g. severe symptoms acute complications). Seek urgent local care.
Important note
This page is for educational and second-opinion purposes. It is not a substitute for emergency care or an in-person exam. If you have urgent symptoms, contact local emergency services.